|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.64 SEK | -2.29% |
|
+1.55% | -13.10% |
| Market Cap | 1.07B 111M 97.02M 89.69M 82.86M 156M 10.66B 159M 420M 5.22B 417M 408M 17.98B | P/E 2026 * |
-13.5x | P/E 2027 * | -26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.05B 109M 95.44M 88.23M 81.51M 153M 10.49B 156M 413M 5.14B 410M 401M 17.69B | EV / Sales 2026 * |
7.58x | EV / Sales 2027 * | 51.7x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | -2.29% | ||
| 1 week | +1.55% | ||
| Current month | -6.70% | ||
| 1 month | +62.31% | ||
| 3 months | +12.10% | ||
| 6 months | -18.00% | ||
| Current year | -13.10% |
| 1 week | 19 |  | 23.5 |
| 1 month | 10.16 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.75 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-10 | Buy | Chairman | 2,750 | 0.0052% | ||
| 03-09 | Buy | Executive/Senior Manager | 1,500 | 0.0028% | ||
| 03-09 | Quantass ApS
| Buy | Company | 7,900 | 0.0148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.29% | +1.55% | -7.14% | -76.78% | 111M | |
| -1.31% | -5.77% | +48.45% | +156.23% | 1,028B | |
| -0.43% | -3.50% | +63.80% | +59.79% | 611B | |
| +1.00% | -2.39% | +32.36% | +82.97% | 432B | |
| +0.84% | -1.55% | +29.29% | +22.93% | 323B | |
| -0.83% | -3.22% | +26.84% | +43.48% | 277B | |
| +1.06% | -11.98% | +19.42% | +22.88% | 257B | |
| +2.89% | +1.62% | -24.17% | -38.73% | 217B | |
| +0.42% | -2.72% | +22.38% | +57.12% | 192B | |
| +0.21% | -3.76% | +19.86% | +68.71% | 161B | |
| Average | +0.18% | -4.30% | +23.11% | +39.86% | 349.84B | |
| Weighted average by Cap. | -0.03% | -5.52% | +36.28% | +77.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.4M 12.59M 11.63M 10.75M 20.24M 1.38B 20.61M 54.44M 677M 54.1M 52.9M 2.33B | 21.15M 2.2M 1.92M 1.77M 1.64M 3.09M 211M 3.14M 8.3M 103M 8.25M 8.06M 356M |
| Net income | 52.18M 5.42M 4.73M 4.38M 4.04M 7.61M 520M 7.75M 20.47M 255M 20.34M 19.89M 877M | -26.04M -2.7M -2.36M -2.18M -2.02M -3.8M -260M -3.87M -10.22M -127M -10.15M -9.93M -438M |
| Net Debt | -17.48M -1.81M -1.59M -1.47M -1.35M -2.55M -174M -2.6M -6.86M -85.34M -6.82M -6.66M -294M | 24.86M 2.58M 2.26M 2.08M 1.93M 3.63M 248M 3.69M 9.75M 121M 9.69M 9.48M 418M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | SEK 19.64 | -2.29% | 111,590 |
| 14/07/26 | SEK 20.10 | -4.74% | 134,541 |
| 13/07/26 | SEK 21.10 | -3.21% | 205,728 |
| 10/07/26 | SEK 21.80 | +2.11% | 432,670 |
| 09/07/26 | SEK 21.35 | +10.39% | 422,177 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
